PURCHASE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- Nutrition 21, Inc. (Nasdaq: NXXI), a growing developer and marketer of nutritional supplements under the Chromax(R), Diabetes Essentials(TM) and Iceland Health(R) brands that help consumers manage blood sugar levels, improve cardiovascular health, enhance memory, and address chronic joint pain, will report financial results for the second quarter of fiscal year 2008, ended December 31, 2007 on Monday, February 11, 2008, after market close. The Company has scheduled a conference call to discuss the results of the quarter on Tuesday, February 12, 2008, at 8:30AM ET.
Participants can dial (866) 562-9910 or (706) 679-5064 to access the conference call, or can listen via a live Internet web cast, which can be found at http://www.nutrition21.com. A replay of the call is available by visiting http://www.nutrition21.com for the next 30 days or by calling (800) 642-1687 or (706) 645-9291, access code 32156566, through February 14, 2008.
About Nutrition 21
Nutrition 21, Inc. (NASDAQ: NXXI), headquartered in Purchase, NY, is a
nutritional bioscience company and the maker of chromium picolinate-based
and omega-3 fish oil-based supplements with health benefits substantiated
by clinical research. Nutrition 21 holds more than 30 patents for nutrition
products and uses. Nutrition 21's portfolio of health and wellness brands
include: Chromax(R), Core4Life(TM) Advanced Memory Formula(TM), Diabetes
Essentials(TM), Iceland Health(R) Maximum Strength Omega-3 and Iceland
Health(R) Joint Relief. The company also manufactures private label
supplements and ingredients for third parties. Nutrition 21 distributes its
products nationally through more than 29,000 major food, drug and super
center retailers as well as internationally. More information is available
Nutrition 21, Inc. Lytham Partners, LLC
Maryrose Lombardo Joe Diaz, Robert Blum, Joe Dorame
914-701-4525 (602) 889-9700
|SOURCE Nutrition 21, Inc.|
Copyright©2008 PR Newswire.
All rights reserved